Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Goodyear

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1981
Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancerM D Goodyear, I R Mackay, I S Russell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphomaR M Meyer, W M Hryniuk, M D Goodyear
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancerI R Mackay, M D Goodyear, C Riglar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trialG P Browman, M D Goodyear, M N Levine, et al.
The New England Journal of Medicine|February 18, 1988
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancerM N Levine, M Gent, J Hirsh, et al.
British Journal of Cancer|January 1, 1992
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiationM N Levine, V Bramwell, H Abu-Zahra, et al.
Cancer|June 15, 1984
Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancerI R Mackay, M D Goodyear, C Riglar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trialG P Browman, M N Levine, M D Goodyear, et al.
Gynecologic Oncology|May 1, 1995
Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometriumM S Carey, G J O'Connell, C R Johanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Quality of life in stage II breast cancer: an instrument for clinical trialsM N Levine, G H Guyatt, M Gent, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cancer Chemotherapy and Pharmacology|January 1, 1981
Delayed recovery of peripheral blood cell numbers after adjuvant cytotoxic chemotherapy for stage II breast cancerM D Goodyear, I R Mackay, I S Russell
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1991
The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphomaR M Meyer, W M Hryniuk, M D Goodyear
Cancer Immunology, Immunotherapy : CII|January 1, 1983
Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancerI R Mackay, M D Goodyear, C Riglar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1990
Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trialG P Browman, M D Goodyear, M N Levine, et al.
The New England Journal of Medicine|February 18, 1988
The thrombogenic effect of anticancer drug therapy in women with stage II breast cancerM N Levine, M Gent, J Hirsh, et al.
British Journal of Cancer|January 1, 1992
The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiationM N Levine, V Bramwell, H Abu-Zahra, et al.
Cancer|June 15, 1984
Effect on immunologic and other indices of adjuvant cytotoxic chemotherapy including melphalan in breast cancerI R Mackay, M D Goodyear, C Riglar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trialG P Browman, M N Levine, M D Goodyear, et al.
Gynecologic Oncology|May 1, 1995
Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometriumM S Carey, G J O'Connell, C R Johanson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
Quality of life in stage II breast cancer: an instrument for clinical trialsM N Levine, G H Guyatt, M Gent, et al.
Pageof 2